Hope Herth Index (HHI): A validation study in Italian patients with solid and hematological malignancies on active cancer treatment

Carla Ida Ripamonti, Loredana Buonaccorso, Alice Maruelli, Elena Bandieri, Stefania Boldini, Maria Adelaide Pessi, Francesca Chiesi, Guido Miccinesi

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Aims and background. Although hope is a widely used term, the experience of hope in patients with chronic or even life-threatening diseases is often disregarded due to the scarcity of carefully designed and validated assessment tools. The aim of this study was to validate the Hope Herth Index (HHI) questionnaire in the Italian population of patients with solid or hematological malignancies during active cancer treatment. Methods. After the translation procedures, the psychometric properties of the Italian version of HHI were evaluated in 266 patients with non-advanced cancer cared for in four different settings. Summative scores ranged from 12-48, with a higher score denoting greater hope. Confirmative factorial analysis was performed to assess dimensionality. The test-retest reliability was assessed by means of the Lin concordance coefficient (two weeks' interval, 80 patients). Concurrent validity was assessed through the following questionnaires: Hospital Anxiety and Depression Scale (HADS), Functional Assessment of Chronic Illness Therapy-Spiritual Well-Being (FACIT-Sp), Edmonton Symptom Assessment Scale (ESAS), and System Belief Inventory (SBI-15R). Results. A total of 266 patients were enrolled. Confirmative factor analysis did not confirm the original three-factor solution, whereas a one-factor solution did perform well. Cronbach's alpha was 0.84 and the test-retest reliability was 0.64 (95% CI 0.51; 0.76). Large convergence was found with spiritual well-being as measured by the FACIT-Sp (0.69) and with anxiety-depression as measured by the HADS (inverse correlation: -0.51). Physical symptoms and religiousness were only slightly correlated, as expected. Conclusions. The Italian version of HHI is a valid and reliable assessment tool - useful to initiate conversation with someone who is troubled but finds it difficult to talk - in patients with either solid or hematological malignancies on active cancer treatment during the non-advanced stages of the disease.

Original languageEnglish
Pages (from-to)385-392
Number of pages8
JournalTumori
Volume98
Issue number3
DOIs
Publication statusPublished - May 2012

Fingerprint

Hope
Validation Studies
Hematologic Neoplasms
Spiritual Therapies
Neoplasms
Anxiety
Depression
Reproducibility of Results
Chronic Disease
Therapeutics
Symptom Assessment
Psychometrics
Statistical Factor Analysis
Equipment and Supplies

Keywords

  • Cancer
  • Hope
  • Hope Herth Index (HHI) Italian version
  • Psychometric properties

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Hope Herth Index (HHI) : A validation study in Italian patients with solid and hematological malignancies on active cancer treatment. / Ripamonti, Carla Ida; Buonaccorso, Loredana; Maruelli, Alice; Bandieri, Elena; Boldini, Stefania; Pessi, Maria Adelaide; Chiesi, Francesca; Miccinesi, Guido.

In: Tumori, Vol. 98, No. 3, 05.2012, p. 385-392.

Research output: Contribution to journalArticle

Ripamonti, CI, Buonaccorso, L, Maruelli, A, Bandieri, E, Boldini, S, Pessi, MA, Chiesi, F & Miccinesi, G 2012, 'Hope Herth Index (HHI): A validation study in Italian patients with solid and hematological malignancies on active cancer treatment', Tumori, vol. 98, no. 3, pp. 385-392. https://doi.org/10.1700/1125.12409
Ripamonti, Carla Ida ; Buonaccorso, Loredana ; Maruelli, Alice ; Bandieri, Elena ; Boldini, Stefania ; Pessi, Maria Adelaide ; Chiesi, Francesca ; Miccinesi, Guido. / Hope Herth Index (HHI) : A validation study in Italian patients with solid and hematological malignancies on active cancer treatment. In: Tumori. 2012 ; Vol. 98, No. 3. pp. 385-392.
@article{bdf33d09445642cebd0b7b28c8d7bf9f,
title = "Hope Herth Index (HHI): A validation study in Italian patients with solid and hematological malignancies on active cancer treatment",
abstract = "Aims and background. Although hope is a widely used term, the experience of hope in patients with chronic or even life-threatening diseases is often disregarded due to the scarcity of carefully designed and validated assessment tools. The aim of this study was to validate the Hope Herth Index (HHI) questionnaire in the Italian population of patients with solid or hematological malignancies during active cancer treatment. Methods. After the translation procedures, the psychometric properties of the Italian version of HHI were evaluated in 266 patients with non-advanced cancer cared for in four different settings. Summative scores ranged from 12-48, with a higher score denoting greater hope. Confirmative factorial analysis was performed to assess dimensionality. The test-retest reliability was assessed by means of the Lin concordance coefficient (two weeks' interval, 80 patients). Concurrent validity was assessed through the following questionnaires: Hospital Anxiety and Depression Scale (HADS), Functional Assessment of Chronic Illness Therapy-Spiritual Well-Being (FACIT-Sp), Edmonton Symptom Assessment Scale (ESAS), and System Belief Inventory (SBI-15R). Results. A total of 266 patients were enrolled. Confirmative factor analysis did not confirm the original three-factor solution, whereas a one-factor solution did perform well. Cronbach's alpha was 0.84 and the test-retest reliability was 0.64 (95{\%} CI 0.51; 0.76). Large convergence was found with spiritual well-being as measured by the FACIT-Sp (0.69) and with anxiety-depression as measured by the HADS (inverse correlation: -0.51). Physical symptoms and religiousness were only slightly correlated, as expected. Conclusions. The Italian version of HHI is a valid and reliable assessment tool - useful to initiate conversation with someone who is troubled but finds it difficult to talk - in patients with either solid or hematological malignancies on active cancer treatment during the non-advanced stages of the disease.",
keywords = "Cancer, Hope, Hope Herth Index (HHI) Italian version, Psychometric properties",
author = "Ripamonti, {Carla Ida} and Loredana Buonaccorso and Alice Maruelli and Elena Bandieri and Stefania Boldini and Pessi, {Maria Adelaide} and Francesca Chiesi and Guido Miccinesi",
year = "2012",
month = "5",
doi = "10.1700/1125.12409",
language = "English",
volume = "98",
pages = "385--392",
journal = "Tumori",
issn = "0300-8916",
publisher = "SAGE Publications Ltd",
number = "3",

}

TY - JOUR

T1 - Hope Herth Index (HHI)

T2 - A validation study in Italian patients with solid and hematological malignancies on active cancer treatment

AU - Ripamonti, Carla Ida

AU - Buonaccorso, Loredana

AU - Maruelli, Alice

AU - Bandieri, Elena

AU - Boldini, Stefania

AU - Pessi, Maria Adelaide

AU - Chiesi, Francesca

AU - Miccinesi, Guido

PY - 2012/5

Y1 - 2012/5

N2 - Aims and background. Although hope is a widely used term, the experience of hope in patients with chronic or even life-threatening diseases is often disregarded due to the scarcity of carefully designed and validated assessment tools. The aim of this study was to validate the Hope Herth Index (HHI) questionnaire in the Italian population of patients with solid or hematological malignancies during active cancer treatment. Methods. After the translation procedures, the psychometric properties of the Italian version of HHI were evaluated in 266 patients with non-advanced cancer cared for in four different settings. Summative scores ranged from 12-48, with a higher score denoting greater hope. Confirmative factorial analysis was performed to assess dimensionality. The test-retest reliability was assessed by means of the Lin concordance coefficient (two weeks' interval, 80 patients). Concurrent validity was assessed through the following questionnaires: Hospital Anxiety and Depression Scale (HADS), Functional Assessment of Chronic Illness Therapy-Spiritual Well-Being (FACIT-Sp), Edmonton Symptom Assessment Scale (ESAS), and System Belief Inventory (SBI-15R). Results. A total of 266 patients were enrolled. Confirmative factor analysis did not confirm the original three-factor solution, whereas a one-factor solution did perform well. Cronbach's alpha was 0.84 and the test-retest reliability was 0.64 (95% CI 0.51; 0.76). Large convergence was found with spiritual well-being as measured by the FACIT-Sp (0.69) and with anxiety-depression as measured by the HADS (inverse correlation: -0.51). Physical symptoms and religiousness were only slightly correlated, as expected. Conclusions. The Italian version of HHI is a valid and reliable assessment tool - useful to initiate conversation with someone who is troubled but finds it difficult to talk - in patients with either solid or hematological malignancies on active cancer treatment during the non-advanced stages of the disease.

AB - Aims and background. Although hope is a widely used term, the experience of hope in patients with chronic or even life-threatening diseases is often disregarded due to the scarcity of carefully designed and validated assessment tools. The aim of this study was to validate the Hope Herth Index (HHI) questionnaire in the Italian population of patients with solid or hematological malignancies during active cancer treatment. Methods. After the translation procedures, the psychometric properties of the Italian version of HHI were evaluated in 266 patients with non-advanced cancer cared for in four different settings. Summative scores ranged from 12-48, with a higher score denoting greater hope. Confirmative factorial analysis was performed to assess dimensionality. The test-retest reliability was assessed by means of the Lin concordance coefficient (two weeks' interval, 80 patients). Concurrent validity was assessed through the following questionnaires: Hospital Anxiety and Depression Scale (HADS), Functional Assessment of Chronic Illness Therapy-Spiritual Well-Being (FACIT-Sp), Edmonton Symptom Assessment Scale (ESAS), and System Belief Inventory (SBI-15R). Results. A total of 266 patients were enrolled. Confirmative factor analysis did not confirm the original three-factor solution, whereas a one-factor solution did perform well. Cronbach's alpha was 0.84 and the test-retest reliability was 0.64 (95% CI 0.51; 0.76). Large convergence was found with spiritual well-being as measured by the FACIT-Sp (0.69) and with anxiety-depression as measured by the HADS (inverse correlation: -0.51). Physical symptoms and religiousness were only slightly correlated, as expected. Conclusions. The Italian version of HHI is a valid and reliable assessment tool - useful to initiate conversation with someone who is troubled but finds it difficult to talk - in patients with either solid or hematological malignancies on active cancer treatment during the non-advanced stages of the disease.

KW - Cancer

KW - Hope

KW - Hope Herth Index (HHI) Italian version

KW - Psychometric properties

UR - http://www.scopus.com/inward/record.url?scp=84867090939&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867090939&partnerID=8YFLogxK

U2 - 10.1700/1125.12409

DO - 10.1700/1125.12409

M3 - Article

C2 - 22825516

AN - SCOPUS:84867090939

VL - 98

SP - 385

EP - 392

JO - Tumori

JF - Tumori

SN - 0300-8916

IS - 3

ER -